LNBR’s User Services Policy

Facilities

Submission period 2022

Performance/usage period 2022

Macromolecules  17/Jan to 25/Nov 24/Jan to 09/Dec
DNA Sequencing (NGS) 03/Jan to 25/Nov 01/Feb to 30/Nov
Metabolomics                               03/Jan to 15/Aug 06/Jan to 15/Aug
Bioprocesses                              03/Jan to 28/Oct 10/Jan to 30/Nov
Pilot Plant                                    25/Apr/ to 27/May July to November

Important Notices

DNA Sequencing, august 2022: Please be advised that we will no longer accept research proposals submitted for the use of the Illumina Hiseq 2500 sequencer in the DNA Sequencing open-access facility. The equipment will be phased out in August 2022 and will soon be replaced by the Illumina NextSeq 2000 Sequencer.

Macromolecules, august 2022: This facility is undergoing unscheduled corrective maintenance of current equipment and refurbishment to introduce new technology. No further proposals will be received in 2022.

LNBR benefits society in a direct way, by leveraging investment made in its research facilities. Access to LNBR advanced instrumentation can enhance scientific and technological developments carried out by external users from academia and industry. Each facility has its own schedule for project submission and execution.

Pilot Plant

End-to-end process design, integration and evaluation with automated control and pretreatment capabilities for different types of biomass.

DNA Sequencing

State-of-art instrumentation for quantitative analysis of genomes and transcriptomes of a variety of biological systems.

Metabolomics

Mass spectrometry-based analysis of various classes of small molecules and metabolites for different biological systems.

Macromolecules

Wide range of instrumentation for biophysical and biochemical characterization of proteins, DNA, carbohydrates, and their interactions.

Bioprocesses

Automated bioreactors of a wide range of scales for yeasts, fungi and bacteria. It is certified to operate with genetically modified organisms.